Clinical trial
Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population
NCT03196661 is registered in ClinicalTrials.gov with Hualan Biological Bacterin Co. Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population
- Lead sponsor
- Hualan Biological Bacterin Co. Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- November 6, 2015
- Completion date
- March 23, 2017
- Enrollment
- 588 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
influenza a